Candida vaginitis: Etiology and susceptibility to antifungal agents;Candidiasis vaginal: Etiología y perfil de sensibilidad a agentes antifúngicos de uso clínico

Revista Argentina de Microbiologia

Volumn 33, Issue 4, 2001, Pages 217-222

  Saporiti, A M ^a   Gomez D ^a   Levalle, S ^a   Galeano, M ^a   Davel, G ^a   Vivot, W ^a   Rodero, L ^a  

^a INSTITUTO NACIONAL DE ENFERMEDADES INFECCIOSAS   (Argentina)

Author keywords

Antifungal resistance; Candidiasis; Vulvovaginitis

Indexed keywords

FLUCONAZOLE; ISOCONAZOLE; KETOCONAZOLE; NYSTATIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDA KRUSEI; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FUNGUS ISOLATION; HUMAN; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PREVALENCE; VAGINA CANDIDIASIS;

ADOLESCENT; ADULT; ANTIFUNGAL AGENTS; ARGENTINA; CANDIDA; CANDIDIASIS, VULVOVAGINAL; COMORBIDITY; CONTRACEPTION; DRUG RESISTANCE, FUNGAL; DRUG RESISTANCE, MULTIPLE, FUNGAL; FEMALE; FLUCONAZOLE; HUMANS; KETOCONAZOLE; MICONAZOLE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NYSTATIN; RISK FACTORS; SPECIES SPECIFICITY; VAGINOSIS, BACTERIAL;

EID: 0035571946     PISSN: 03257541     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Relación entre la presencia de Candida y la flora microbiana de las vaginitis
2. Influencia de los mėtodos anticonceptivos sobre la flora vaginal y su relación con la vaginitis candidiásica
3. Incidencia de las vaginitis candidiȧsicas en diferentes grupos etarios. Su relación con otras formas de vaginitis y con la fisiología vaginal
4. Estudio de las condiciones de formación de las clamidosporas
5. Candida glabrata: Review of epidemiology, pathogenesis, and clinical disease whit comparison to C. albicans
6. Chronic vulvovaginal candidiasis. Characteristic of women with Candida albicans, Candida glabrata and no Candida
7. Role of antifungal drug resistance in the pathogenesis of recurrent vulvovaginal candidiasis
8. Candidosis of the genitalia
9. Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents
10. Antifungal susceptibility testing of yeast: Evaluation of technical variables for tests automatization
11. Development of interpretative breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in vitro - In vivo correlation data for fluconazole, itraconazole, and Candida infections
12. Improved medium for fluconazole susceptibility testing of Candida albicans
13. Vulvovaginal candidiasis: Epidemiologic, diagnostic and therapeutic considerations
14. Vaginal infection in adult woman
15. Vulvovaginitis due to Candida glabrata. An emerging problem
16. Methods for isolation, maintenance, classification and identification of yeasts
17. Evolution of vaginal Candida species recovered from human immunodeficiency virus-infected women receiving fluconazole profilaxis: The emergence of Candida glabrata?
18. Clinical, cellular and molecular factors that contribute to antifungal drug resistance